In‐stent restenosis (ISR) remains a significant challenge in interventional cardiology, with limited long‐term effective treatment options. Intravascular brachytherapy (IVB) has reemerged as a viable treatment modality for ISR, yet predictors… Click to show full abstract
In‐stent restenosis (ISR) remains a significant challenge in interventional cardiology, with limited long‐term effective treatment options. Intravascular brachytherapy (IVB) has reemerged as a viable treatment modality for ISR, yet predictors of treatment failure remain poorly characterized. This study evaluates the clinical outcomes and identifies predictors of failure following IVB in patients with coronary ISR.
               
Click one of the above tabs to view related content.